Citation Impact
Citing Papers
Phenotypic and functional features of human Th17 cells
2007 Standout
Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party
2007
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Role of viruses in etiology and pathogenesis of multiple sclerosis
2001
Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation
2002
Virus-Induced Autoimmunity: Potential Role of Viruses in Initiation, Perpetuation, and Progression of T-Cell–Mediated Autoimmune Disease
2001
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
2005 Standout
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial
2003
Expression of tumor necrosis factor-α and interferon-γ mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis
2002
Treatment of multiple sclerosis with Copolymer-1 (Copaxone®): implicating mechanisms of Th1 to Th2/Th3 immune-deviation
1998
Staphylococcal enterotoxin B and tumor‐necrosis factor‐α‐induced relapses of experimental allergic encephalomyelitis: Protection by transforming growth factor‐β and interleukin‐10
1995
Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance
2010
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Augmented expression of tumour necrosis factor-α and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis
1996
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-$alpha;
2003
A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis
2003
Structure and function of the blood–brain barrier
2009 Standout
Central nervous system injury-induced immune deficiency syndrome
2005 Standout
Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
1997
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation
2010
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
The Transplantation of Hematopoietic Stem Cells After Non-Myeloablative Conditioning: A Cellular Therapeutic Approach to Hematologic and Genetic Diseases
2003
Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: Correlation with demyelinating activity and oligodendrocyte pathology
2000
Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genes
2001
TNF, Apoptosis and Autoimmunity: A Common Thread?
1998 StandoutNobel
Mucosal immunity and vaccines
2005 Standout
Infectious agents and different course of multiple sclerosis: a systematic review
2018
Vascular disorders of the liver # †
2008 Standout
Stressor-Induced Alteration of Cytokine Production in Multiple Sclerosis Patients and Controls
1998
Review of “Minitransplantation”: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation
2003
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
2008
Acute myeloid leukaemia
2006
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
2009 Standout
Tumor necrosis factor α-308 alleles in multiple sclerosis and optic neuritis
1995
The activation of protein kinase C induces higher production of reactive oxygen species by mononuclear cells in patients with multiple sclerosis than in controls
1999
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Immunopathology of multiple sclerosis
2015 Standout
Levels of IL‐15 in Serum and Cerebrospinal Fluid of Patients with Behçet's Disease
2006
Mechanisms of Immune Injury in Multiple Sclerosis
1996
Graft-versus-host disease
2009 Standout
Recognition of Conserved Amino Acid Motifs of Common Viruses and Its Role in Autoimmunity
2005 StandoutNobel
Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis
1999
Adhesion molecule expression and regulation on cells of the central nervous system
1999
The immunology of stroke: from mechanisms to translation
2011 Standout
Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood
1997
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy
2004 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Allogeneic transplantation of blood stem cells: Coming of age?
2001
IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-α, TGF-β1 and blood–brain barrier function
1999
Increased ability of peripheral blood lymphocytes to degrade laminin in multiple sclerosis
2004
FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier
1999
Idarucizumab for Dabigatran Reversal
2015 Standout
Regulation of type I interferon responses
2013 Standout
Nutrition Issues in Hematopoietic Stem Cell Transplantation: State of the Art
2005
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Therapeutic Approaches in Multiple Sclerosis
2002
Synergistic immunomodulatory effects of interferon‐β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing‐remitting multiple sclerosis
1998
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
The Pathobiology of Vascular Dementia
2013 Standout
Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
2006
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions
1997
Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation
2005
Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages
2016 Standout
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
2000 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis
2006 Standout
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
2005 Standout
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities
2004
Prevention and Treatment of Cancer-Related Infections
2012
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
IL-17 and Th17 Cells
2009 Standout
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
1999
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells
2003
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
2004
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies
2003
Association between clinical disease activity and Epstein–Barr virus reactivation in MS
2000
Interleukin‐12 and Perforin mRNA Expression is Augmented in Blood Mononuclear Cells in Multiple Sclerosis
1998
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Menstrual cycle effects on cortical excitability
1999
Novel therapeutics for the treatment of graft-versus-host disease
2002
Works of A Helwig being referenced
Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF
2001
Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia
2001
Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin
2000
Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activity
1995
SUCCESSFUL PREEMPTIVE CIDOFOVIR TREATMENT FOR CMV ANTIGENEMIA AFTER DOSE-REDUCED CONDITIONING AND ALLOGENEIC BLOOD STEM CELL TRANSPLANTATION
2001
Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.
2001
Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients a with multinle sclerosis
1994